Stock_Titan
Posted - 5 days ago
$PRAX Praxis Precision Medicines to Present on Ulixacaltamide at the American Academy of Neurology 2024 Annual Meeting
https://www.stocktitan.net/news/PRAX/praxis-precision-medicines-to-present-on-ulixacaltamide-at-the-o0psf4p08jth.html
G101SPM
Posted - 6 days ago
$PRAX $52.11 bid. DAC (dollar average cost) $23.25 last $15.50 (11.29.23). FIX EXIT at $95.00 as Legacy Holding (LH) distinction. OVERVIEW: Positive results of PRAX-628 study evaluating photo paroxysmal response, achieving 100% response in treated patients. ^In the 45 mg cohort, 100% of patients achieved a complete response. ^In the 15 mg cohort, 80% of patients achieved a complete response and 20% achieved a partial response. ^Safety was consistent with prior dose escalation study and PK analysis confirmed therapeutic exposures. Praxis plans to initiate an efficacy study in focal onset epilepsy in the SECOND HALF OF 2024. second half of 2024.
WizeKing44
Posted - 1 week ago
$RNAC Why is this up today? Tutes have permission to buy. Look at $JSPR $PRAX etc.
R84877P
Posted - 1 week ago
$PRAX Let's go!
Stock_Titan
Posted - 1 week ago
$PRAX Praxis Precision Medicines to Participate in Upcoming April Conferences
https://www.stocktitan.net/news/PRAX/praxis-precision-medicines-to-participate-in-upcoming-april-9gpfoyrfkfqt.html
MaverikIT
Posted - 1 week ago
@net0trader @DonCorleone77 @IsabellaDC @Cash4freedom @Wigglyick @Im_not_Mr_Lebowski @RonIsWrong Ron, $PRAX - another leg$ up ?
Stock_Titan
Posted - 2 weeks ago
$PRAX Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
https://www.stocktitan.net/news/PRAX/praxis-precision-medicines-inc-announces-inducement-grants-under-xquwf9eir0pc.html
Constantine
Posted - 2 weeks ago
$PRAX gap @ $55.50 filled
AnalRetort
Posted - 03/29/24
@JoshThe3rd $Prax fan here. It's been lonely on twits as it's mostly tuts. I would love some company. I agree with your comments, fyi the company did an offering in January too they burn cash but not that fast, I'm thinking they have about $400m ~$450m cash on hand factor that in when valuing. ET has a good chance of success due to trial design, the emphasis is on patient reported outcomes - not dr measured outcomes. BIG DIFFERENCE. Also 628's flashing light test was unheard of to have all cr's. The best medication for epilepsy scored 1/3rd cr's. Yet to be seen what happens in the real world though, larger trials are needed. Also prax 222 and prax 562 while targeting orphan epilepsies could bring in 200+400m a year.
JoshThe3rd
Posted - 03/29/24
$PRAX I like my odds of an MLTX style run. Low float + Cormorant has 14% ownership over 2 funds. Mediocre treatments for ET propranolol (for high blood pressure) and primadone (anticonvulsants). 200M funding secured at 56.50. 4B market opportunity for ET + 3B market for Epilepsy (though focus is on ET, PRAX-628 is a great bonus)
AnalRetort
Posted - 03/28/24
@VictorMason @Theshermank despite a 200m offering $prax is above the offering price ($56) traded over $60. Hey man if you can't beat them join them.
WizeKing44
Posted - 03/28/24
$RNAC This is true. Check out $JSPR and $PRAX
MaverikIT
Posted - 03/28/24
@IsabellaDC @net0trader @RonIsWrong @Wigglyick $PRAX - nice. tagging on
DonCorleone77
Posted - 03/28/24
$PRAX Praxis Precision Medicines 3.32M share Spot Secondary priced at $56.50 Piper Sandler, Guggenheim and Truist acted as joint book running managers for the offering.
Constantine
Posted - 03/28/24
$PRAX $56.50 is a good price for the offering
Stock_Titan
Posted - 03/27/24
$PRAX Praxis Precision Medicines, Inc. Announces Pricing of $200 Million Public Offering
https://www.stocktitan.net/news/PRAX/praxis-precision-medicines-inc-announces-pricing-of-200-million-vi33c3bqseqw.html
JoshThe3rd
Posted - 03/27/24
$PRAX offering here 👀 very nice stairway financing
buddyopalosam
Posted - 03/27/24
$PRAX wow another offering. If there is no news for a few months this might slowly bleed to low 40s again.
Theshermank
Posted - 03/27/24
@AnalRetort @VictorMason all this data and somehow I'm almost certain $PRAX will mess it up just like how they messed up the mdd and essential tremor trials.
AnalRetort
Posted - 03/27/24
$PRAX massive $750m offering, dilution sucks and this is no different but wow, that's a big one. Little guy always gets shafted in these things but what can one do. This investor writing this would think this is the final dilution until profitability.
DonCorleone77
Posted - 03/27/24
$PRAX Praxis Precision Medicines announces offering of common stock, warrants Praxis Precision Medicines announced a proposed public offering of its common stock and, in lieu of common stock to certain investors, prefunded warrants to purchase shares of common stock. All securities in the offering will be offered by Praxis. Piper Sandler, Guggenheim Securities and Truist Securities are acting as joint book-running managers for the offering. H.C. Wainwright & Co. and Needham & Company are acting as co-lead managers for the offering.
Stock_Titan
Posted - 03/27/24
$PRAX Praxis Precision Medicines, Inc. Announces Proposed Public Offering
https://www.stocktitan.net/news/PRAX/praxis-precision-medicines-inc-announces-proposed-public-jbkxj5ytymwb.html
Theshermank
Posted - 03/27/24
@AnalRetort @VictorMason Hahahah, please get serious. $PRAX is a joke of a company ran by a CEO whose track record and execution is akin to a “crackhead,” basically botching every key trial in the companies history . Also, those top doctors are exactly the same ones that almost got PRAX 0.10$ off getting delisted from the stock exchange. Come back to me when the P3 trial blows up like everything else that $PRAX has ever tried, including the mdd trial that they somehow botched worse than $RLMD last year 😂
bullfrog_swings
Posted - 03/27/24
$PRAX glad I sold it yesterday
Thestocktraderhubzee
Posted - 03/27/24
WATCHLIST MAR 27 2024
$APA APA shares are trading lower after Goldman Sachs maintained a Sell rating on the stock and lowered its price target from $35 to $31.
$ES UBS Maintains Neutral on Eversource Energy, Maintains $62 Price Target
$VKTX Oppenheimer Maintains Outperform on Viking Therapeutics, Raises Price Target to $138
$SQ Evercore ISI Group Maintains In-Line on Block, Maintains $75 Price Target
$PRAX Jefferies Maintains Buy on Praxis Precision Medicine, Raises Price Target to $128
Theshermank
Posted - 03/26/24
@AnalRetort Also $PRAX the company that you seem heavily invested in literally had this headline only last july
Quantumup
Posted - 03/26/24
Jefferies raised PT $PRAX $128 was $75/Buy~says "PRAX-628 exceeded our expectations with 100% complete suppression in the 45 mg cohort:" H.C. Wainwright $PRAX (Buy/$105) PPR results gives PRAX a much-needed clear "win" /boosts Co's credibility into additional readouts this year:
AnalRetort
Posted - 03/26/24
Celebrating a win in $prax today! let's see what happens after the market closes on my other pick $glyc! Good luck... It's not an accident I'm here I have a good feeling about this one.
QuizNose
Posted - 03/26/24
$PRAX awesome results - 52-wk high earlier. Too bad it’s been a fader since the surge to $67.
Been here since mid-Dec. this is a buy and hold stock.
DorisRooker793
Posted - 03/26/24
$PRAX How is TREIF's technology improving healthcare accessibility?